Effectiveness of Vestibular Rehabilitation for Improving Health Status in Patients With Fibromyalgia
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this study is to analyze the effectiveness of Vestibular Rehabilitation for improving balance and quality of life of patients with Fibromyalgia Syndrome (SFM). Recruited subjects will be randomly assigned to an experimental group or control group (placebo). The experimental group will receive a standard Vestibular Rehabilitation program focused on eye stabilization and Vestibulo-Ocular Reflex (VOR) gain with the aim of improving motor and sensory strategies, while the control group will carry out a conventional rehabilitation program that will not include sensory strategy training. The frequency of treatment for both groups will be twice/week, along with daily performing (2 times/day, 5 days/week) of exercises at home. The total duration will be 8 weeks. The outcome measure are: disease impact (FIQ), perceived vertigo (DHI), and confidence in balance (ABC), at pre-treatment, post-treatment, one month follow-up and three months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedNovember 3, 2022
October 1, 2022
7 months
January 24, 2022
October 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
Baseline
FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
at eight weeks
FIQ (Fibromyalgia Impact Questionnaire)
Evaluates the impact of fibromyalgia on the patient's quality of life.The total score of the FIQ is from 0 to 100. A higher score means a greater impact of the disease on the patient.
at twelve weeks
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
Baseline
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
at eight weeks
ABC-16 (Activities-specific Balance Confidence scale-16 items)
Evaluates the balance confidence in performing activities of daily living. The total score of the ABC-16 is from 0% to 100%, with higher values associated with higher balance confidence.
at twelve weeks
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
Baseline
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
at eight weeks
DHI (Dizziness Handicap Inventory)
Evaluates the level of disability related to the impact of dizziness on daily function and quality of life. The total score of the DHI is from 0 to100 points. A higher score indicates a greater degree of disability due to the vertiginous symptoms.
at twelve weeks.
Secondary Outcomes (33)
CSI (Central Sensitization Inventory)
Baseline
CSI (Central Sensitization Inventory)
at eight weeks
CSI (Central Sensitization Inventory)
at twelve weeks.
PCS (Pain Catastrophizing Scale)
Baseline
PCS (Pain Catastrophizing Scale)
at eight weeks
- +28 more secondary outcomes
Other Outcomes (4)
Height (Anthropometrics Data)
Baseline
Weight (Anthropometrics Data)
Baseline
Body Mass Index (Anthropometrics Data)
Baseline
- +1 more other outcomes
Study Arms (2)
Vestibular Rehabilitation Exercises
EXPERIMENTALVestibular Rehabilitation Exercises focused on eye stabilization and Vestibulo-Oculo Reflex (VOR). Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)
Conventional Rehabilitation exercises
SHAM COMPARATORConventional rehabilitation exercises: stretching and walking. Two sessions/week supervised by researcher (40 min) and conducting exercises at home 2 times/day, 5 days/week. (15-20 min)
Interventions
The Vestibular Rehabilitation program focuses on stabilizing the gaze and gaining the Vestibular Ocular Reflex (VOR). The general mechanisms of recovery from vestibular injuries are vestibular adaptation and replacement exercises, which are designed to improve gaze stability and the interaction between sight and the vestibular system during head movements. The exercises will be carried out progressively according to the tolerance of the patient, varying the stimulus in intensity and frequency.
The conventional rehabilitation program in which exercises are performed to improve joint range, flexibility, and gait. It will always be done with the eyes open, on a firm surface and will not include training in sensory strategies
Eligibility Criteria
You may qualify if:
- Aged 18-70 years,
- Diagnostic for fibromyalgia as described by the 2016 American College of Rheumatology (ACR)
You may not qualify if:
- Cognitive impairment impacting ability to fill out the scales and questionnaires.
- Musculoskeletal surgical intervention in the preceding 6 months and/or acute traumatic pathology to the inferior limb(s).
- Musculoskeletal disease with deformity of the inferior limbs.
- Diagnosed with vestibular, visual and/or auditory pathology.
- Neurologic illness that could be the cause of a balance disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University os Jaén
Jaén, 23071, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rafael Lomas-Vega, PhD
University of Jaén
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student, principal investigator
Study Record Dates
First Submitted
January 24, 2022
First Posted
March 29, 2022
Study Start
June 1, 2021
Primary Completion
December 20, 2021
Study Completion
April 1, 2022
Last Updated
November 3, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share